BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36123378)

  • 1. TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells.
    Liu J; Shu G; Wu A; Zhang X; Zhou Z; Alvero AB; Mor G; Yin G
    Sci Rep; 2022 Sep; 12(1):15650. PubMed ID: 36123378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
    Chen J; Hu Q; Zhou C; Jin D
    Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.
    Yin G; Alvero AB; Craveiro V; Holmberg JC; Fu HH; Montagna MK; Yang Y; Chefetz-Menaker I; Nuti S; Rossi M; Silasi DA; Rutherford T; Mor G
    Oncogene; 2013 Jan; 32(1):39-49. PubMed ID: 22349827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.
    Chang YW; Su YJ; Hsiao M; Wei KC; Lin WH; Liang CL; Chen SC; Lee JL
    Cancer Res; 2015 Aug; 75(16):3398-410. PubMed ID: 26122848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
    Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
    PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
    Wei C; Zhang X; He S; Liu B; Han H; Sun X
    Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
    Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE/AKT/β-catenin/SLUG axis.
    Bu S; Wang Q; Sun J; Li X; Gu T; Lai D
    Cell Death Dis; 2020 Aug; 11(8):644. PubMed ID: 32811805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
    Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
    Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/β-catenin pathway.
    Miao W; Lu T; Liu X; Yin W; Zhang H
    Cancer Biomark; 2020; 28(4):459-471. PubMed ID: 32538821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer.
    Koo YJ; Kim TJ; Min KJ; So KA; Jung US; Hong JH
    Tumour Biol; 2017 May; 39(5):1010428317706226. PubMed ID: 28488542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.
    Li J; Zhou BP
    BMC Cancer; 2011 Feb; 11():49. PubMed ID: 21284870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.